Genetics and Genomic Studies in Scleroderma (Systemic Sclerosis)

Rheumatic Disease Clinics of North America

Volumn 34, Issue 1, 2008, Pages 17-40

  Agarwal, Sandeep K ^a   Tan, Filemon K ^a   Arnett, Frank C ^a  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACID PROTEIN; ALLOGRAFT INFLAMMATORY FACTOR 1; CHEMOKINE; CONNECTIVE TISSUE GROWTH FACTOR; CYSTEINE; DIPEPTIDYL CARBOXYPEPTIDASE; ENDOTHELIN 1; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; MACROPHAGE MIGRATION INHIBITION FACTOR; NITRIC OXIDE SYNTHASE; PROTEIN TYROSINE PHOSPHATASE; PROTEIN TYROSINE PHOSPHATASE NON RECEPTOR 22; TRANSFORMING GROWTH FACTOR BETA1; UNCLASSIFIED DRUG; VASCULOTROPIN;

AUTOIMMUNITY; ETHNICITY; EXTRACELLULAR MATRIX; FAMILY; FIBROSIS; GENE; GENETIC LINKAGE; GENETICS; GENOME; GENOMICS; HEREDITY; HLA SYSTEM; HUMAN; MICROARRAY ANALYSIS; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROGNOSIS; PROTEIN SECRETION; REVIEW; RISK; SCLERODERMA; SYSTEMIC SCLEROSIS; TWINS;

EID: 40349098515     PISSN: 0889857X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.rdc.2007.10.001     Document Type: Review

References (146)

1. F.C. Arnett HLA and autoimmunity in scleroderma (systemic sclerosis) Int Rev Immunol 12 2–4 1995 107 128
2. T.A. Medsger Jr. Epidemiology of systemic sclerosis Clin Dermatol 12 2 1994 207 216
3. T.A. Medsger Jr. A.T. Masi Epidemiology of systemic sclerosis (scleroderma) Ann Intern Med 74 5 1971 714 721
4. V.D. Steen C.V. Oddis C.G. Conte Incidence of systemic sclerosis in Allegheny County, Pennsylvania. A twenty-year study of hospital-diagnosed cases, 1963–1982 Arthritis Rheum 40 3 1997 441 445
5. C.J. Michet Jr. C.H. McKenna L.R. Elveback Epidemiology of systemic lupus erythematosus and other connective tissue diseases in Rochester, Minnesota, 1950 through 1979 Mayo Clin Proc 60 2 1985 105 113
6. M.D. Mayes J.V. Lacey Jr. J. Beebe-Dimmer Prevalence, incidence, survival, and disease characteristics of systemic sclerosis in a large US population Arthritis Rheum 48 8 2003 2246 2255
7. A.R. McGregor A. Watson E. Yunis Familial clustering of scleroderma spectrum disease Am J Med 84 6 1988 1023 1032
8. H. Englert J. Small-McMahon P. Chambers Familial risk estimation in systemic sclerosis Aust N Z J Med 29 1 1999 36 41
9. F.C. Arnett M. Cho S. Chatterjee Familial occurrence frequencies and relative risks for systemic sclerosis (scleroderma) in three United States cohorts Arthritis Rheum 44 6 2001 1359 1362
10. S. Assassi F.C. Arnett J.D. Reveille Clinical, immunologic, and genetic features of familial systemic sclerosis Arthritis Rheum 56 6 2007 2031 2037
11. N.J. Cook A.J. Silman J. Propert Features of systemic sclerosis (scleroderma) in an identical twin pair Br J Rheumatol 32 10 1993 926 928
12. F. De Keyser I. Peene R. Joos Occurrence of scleroderma in monozygotic twins J Rheumatol 27 9 2000 2267 2269
13. C. Feghali-Bostwick T.A. Medsger Jr. T.M. Wright Analysis of systemic sclerosis in twins reveals low concordance for disease and high concordance for the presence of antinuclear antibodies Arthritis Rheum 48 7 2003 1956 1963
14. X. Zhou F.K. Tan M. Xiong Monozygotic twins clinically discordant for scleroderma show concordance for fibroblast gene expression profiles Arthritis Rheum 52 10 2005 3305 3314
15. T.J. Laing B.W. Gillespie M.B. Toth Racial differences in scleroderma among women in Michigan Arthritis Rheum 40 4 1997 734 742
16. J.D. Reveille M. Fischbach T. McNearney Systemic sclerosis in 3 US ethnic groups: a comparison of clinical, sociodemographic, serologic, and immunogenetic determinants Semin Arthritis Rheum 30 5 2001 332 346
17. F.C. Arnett R.F. Howard F. Tan Increased prevalence of systemic sclerosis in a Native American tribe in Oklahoma. Association with an Amerindian HLA haplotype Arthritis Rheum 39 8 1996 1362 1370
18. F.K. Tan D.N. Stivers M.W. Foster Association of microsatellite markers near the fibrillin 1 gene on human chromosome 15q with scleroderma in a Native American population Arthritis Rheum 41 10 1998 1729 1737
19. F.K. Tan N. Wang M. Kuwana Association of fibrillin 1 single-nucleotide polymorphism haplotypes with systemic sclerosis in Choctaw and Japanese populations Arthritis Rheum 44 4 2001 893 901
20. L.D. Siracusa R. McGrath Q. Ma A tandem duplication within the fibrillin 1 gene is associated with the mouse tight skin mutation Genome Res 6 4 1996 300 313
21. F.C. Arnett W.B. Bias J.D. Reveille Genetic studies in Sjogren's syndrome and systemic lupus erythematosus J Autoimmun 2 4 1989 403 413
22. L. Schlosstein P.I. Terasaki R. Bluestone High association of an HL-A antigen, W27, with ankylosing spondylitis N Engl J Med 288 14 1973 704 706
23. G.T. Nepom C.E. Seyfried S.L. Holbeck Identification of HLA-Dw14 genes in DR4+ rheumatoid arthritis Lancet 2 8514 1986 1002 1005
24. F.K. Tan F.C. Arnett Genetic factors in the etiology of systemic sclerosis and Raynaud phenomenon Curr Opin Rheumatol 12 6 2000 511 519
25. F.K. Tan Systemic sclerosis: the susceptible host (genetics and environment) Rheum Dis Clin North Am 29 2 2003 211 237
26. ∗0501 is associated with diffuse systemic sclerosis in Caucasian men Arthritis Rheum 43 9 2000 2005 2010
27. J.D. Reveille E. Durban M.J. MacLeod-St Clair Association of amino acid sequences in the HLA-DQB1 first domain with antitopoisomerase I autoantibody response in scleroderma (progressive systemic sclerosis) J Clin Invest 90 3 1992 973 980
28. F.K. Tan D.N. Stivers F.C. Arnett HLA haplotypes and microsatellite polymorphisms in and around the major histocompatibility complex region in a Native American population with a high prevalence of scleroderma (systemic sclerosis) Tissue Antigens 53 1 1999 74 80
29. M. Kuwana J. Kaburaki Y. Okano The HLA-DR and DQ genes control the autoimmune response to DNA topoisomerase I in systemic sclerosis (scleroderma) J Clin Invest 92 3 1993 1296 1301
30. M. Kuwana T.A. Medsger Jr. T.M. Wright T cell proliferative response induced by DNA topoisomerase I in patients with systemic sclerosis and healthy donors J Clin Invest 96 1 1995 586 596
31. P.A. Morel H.J. Chang J.W. Wilson Severe systemic sclerosis with anti-topoisomerase I antibodies is associated with an HLA-DRw11 allele Hum Immunol 40 2 1994 101 110
32. F.C. Gilchrist C. Bunn P.J. Foley Class II HLA associations with autoantibodies in scleroderma: a highly significant role for HLA-DP Genes Immun 2 2 2001 76 81
33. P.A. Morel H.J. Chang J.W. Wilson HLA and ethnic associations among systemic sclerosis patients with anticentromere antibodies Hum Immunol 42 1 1995 35 42
34. F.C. Arnett J.D. Reveille R. Goldstein Autoantibodies to fibrillarin in systemic sclerosis (scleroderma). An immunogenetic, serologic, and clinical analysis Arthritis Rheum 39 7 1996 1151 1160
35. C. Marguerie C.C. Bunn J. Copier The clinical and immunogenetic features of patients with autoantibodies to the nucleolar antigen PM-Scl Medicine (Baltimore) 71 6 1992 327 336
36. G.C. Fanning K.I. Welsh C. Bunn HLA associations in three mutually exclusive autoantibody subgroups in UK systemic sclerosis patients Br J Rheumatol 37 2 1998 201 207
37. D. Falkner J. Wilson N. Fertig Studies of HLA-DR and DQ alleles in systemic sclerosis patients with autoantibodies to RNA polymerases and U3-RNP (fibrillarin) J Rheumatol 27 5 2000 1196 1202
38. H. Campbell I. Rudan Interpretation of genetic association studies in complex disease Pharmacogenomics J 2 6 2002 349 360
39. K.E. Lohmueller C.L. Pearce M. Pike Meta-analysis of genetic association studies supports a contribution of common variants to susceptibility to common disease Nat Genet 33 2 2003 177 182
40. L. Caponi E. Petit-Teixeira M. Sebbag A family based study shows no association between rheumatoid arthritis and the PADI4 gene in a white French population Ann Rheum Dis 64 4 2005 587 593
41. C.P. Kang H.S. Lee H. Ju A functional haplotype of the PADI4 gene associated with increased rheumatoid arthritis susceptibility in Koreans Arthritis Rheum 54 1 2006 90 96
42. A. Martinez A. Valdivia D. Pascual-Salcedo PADI4 polymorphisms are not associated with rheumatoid arthritis in the Spanish population Rheumatology (Oxford) 44 10 2005 1263 1266
43. R.M. Plenge L. Padyukov E.F. Remmers Replication of putative candidate-gene associations with rheumatoid arthritis in >4,000 samples from North America and Sweden: association of susceptibility with PTPN22, CTLA4, and PADI4 Am J Hum Genet 77 6 2005 1044 1060
44. A. Suzuki R. Yamada X. Chang Functional haplotypes of PADI4, encoding citrullinating enzyme peptidylarginine deiminase 4, are associated with rheumatoid arthritis Nat Genet 34 4 2003 395 402
45. A.B. Begovich V.E. Carlton L.A. Honigberg A missense single-nucleotide polymorphism in a gene encoding a protein tyrosine phosphatase (PTPN22) is associated with rheumatoid arthritis Am J Hum Genet 75 2 2004 330 337
46. S. Kanangat A.E. Postlethwaite G.C. Higgins Novel functions of intracellular IL-1ra in human dermal fibroblasts: implications in the pathogenesis of fibrosis J Invest Dermatol 126 4 2006 756 765
47. Y. Kawaguchi M. Hara T.M. Wright Endogenous IL-1alpha from systemic sclerosis fibroblasts induces IL-6 and PDGF-A J Clin Invest 103 9 1999 1253 1260
48. Y. Kawaguchi S.A. McCarthy S.C. Watkins Autocrine activation by interleukin 1alpha induces the fibrogenic phenotype of systemic sclerosis fibroblasts J Rheumatol 31 10 2004 1946 1954
49. Y. Kawaguchi A. Tochimoto N. Ichikawa Association of IL1A gene polymorphisms with susceptibility to and severity of systemic sclerosis in the Japanese population Arthritis Rheum 48 1 2003 186 192
50. B. Hutyrova J. Lukac V. Bosak Interleukin 1alpha single-nucleotide polymorphism associated with systemic sclerosis J Rheumatol 31 1 2004 81 84
51. L. Beretta F. Bertolotti F. Cappiello Interleukin-1 gene complex polymorphisms in systemic sclerosis patients with severe restrictive lung physiology Hum Immunol 68 7 2007 603 609
52. S. Mattuzzi S. Barbi A. Carletto Association of polymorphisms in the IL1B and IL2 genes with susceptibility and severity of systemic sclerosis J Rheumatol 34 5 2007 997 1004
53. U. Utans R.J. Arceci Y. Yamashita Cloning and characterization of allograft inflammatory factor-1: a novel macrophage factor identified in rat cardiac allografts with chronic rejection J Clin Invest 95 6 1995 2954 2962
54. F. Del Galdo G.G. Maul S.A. Jimenez Expression of allograft inflammatory factor 1 in tissues from patients with systemic sclerosis and in vitro differential expression of its isoforms in response to transforming growth factor beta Arthritis Rheum 54 8 2006 2616 2625
55. U. Utans W.C. Quist B.M. McManus Allograft inflammatory factory-1. A cytokine-responsive macrophage molecule expressed in transplanted human hearts Transplantation 61 9 1996 1387 1392
56. F. Del Galdo C.M. Artlett S.A. Jimenez The role of allograft inflammatory factor 1 in systemic sclerosis Curr Opin Rheumatol 18 6 2006 588 593
57. F.D. Galdo S.A. Jimenez T cells expressing allograft inflammatory factor 1 display increased chemotaxis and induce a profibrotic phenotype in normal fibroblasts in vitro Arthritis Rheum 56 10 2007 3478 3488
58. F.G. Otieno A.M. Lopez S.A. Jimenez Allograft inflammatory factor-1 and tumor necrosis factor single nucleotide polymorphisms in systemic sclerosis Tissue Antigens 69 6 2007 583 591
59. F. Alkassab P. Gourh F.K. Tan An allograft inflammatory factor 1 (AIF1) single nucleotide polymorphism (SNP) is associated with anticentromere antibody positive systemic sclerosis Rheumatology (Oxford) 46 8 2007 1248 1251
60. N. Bottini L. Musumeci A. Alonso A functional variant of lymphoid tyrosine phosphatase is associated with type I diabetes Nat Genet 36 4 2004 337 338
61. M. Rieck A. Arechiga S. Onengut-Gumuscu Genetic variation in PTPN22 corresponds to altered function of T and B lymphocytes J Immunol 179 7 2007 4704 4710
62. T. Vang M. Congia M.D. Macis Autoimmune-associated lymphoid tyrosine phosphatase is a gain-of-function variant Nat Genet 37 12 2005 1317 1319
63. S. Onengut-Gumuscu K.G. Ewens R.S. Spielman A functional polymorphism (1858C/T) in the PTPN22 gene is linked and associated with type I diabetes in multiplex families Genes Immun 5 8 2004 678 680
64. G. Orozco E. Sanchez M.A. Gonzalez-Gay Association of a functional single-nucleotide polymorphism of PTPN22, encoding lymphoid protein phosphatase, with rheumatoid arthritis and systemic lupus erythematosus Arthritis Rheum 52 1 2005 219 224
65. G. Orozco C. Garcia-Porrua M.A. Lopez-Nevot Lack of association between ankylosing spondylitis and a functional polymorphism of PTPN22 proposed as a general susceptibility marker for autoimmunity Ann Rheum Dis 65 5 2006 687 688
66. M. van Oene R.F. Wintle X. Liu Association of the lymphoid tyrosine phosphatase R620W variant with rheumatoid arthritis, but not Crohn's disease, in Canadian populations Arthritis Rheum 52 7 2005 1993 1998
67. M. Ittah J.E. Gottenberg A. Proust No evidence for association between 1858 C/T single-nucleotide polymorphism of PTPN22 gene and primary Sjogren's syndrome Genes Immun 6 5 2005 457 458
68. E. Balada C.P. Simeon-Aznar S. Serrano-Acedo Lack of association of the PTPN22 gene polymorphism R620W with systemic sclerosis Clin Exp Rheumatol 24 3 2006 321 324
69. ∗620W allele and systemic sclerosis in the French Caucasian population Ann Rheum Dis 65 9 2006 1230 1232
70. P. Gourh F.K. Tan S. Assassi Association of the PTPN22 R620W polymorphism with anti-topoisomerase I- and anticentromere antibody-positive systemic sclerosis Arthritis Rheum 54 12 2006 3945 3953
71. M. Bacher A. Meinhardt H.Y. Lan Migration inhibitory factor expression in experimentally induced endotoxemia Am J Pathol 150 1 1997 235 246
72. T. Calandra J. Bernhagen R.A. Mitchell The macrophage is an important and previously unrecognized source of macrophage migration inhibitory factor J Exp Med 179 6 1994 1895 1902
73. E.F. Morand M. Leech H. Weedon Macrophage migration inhibitory factor in rheumatoid arthritis: clinical correlations Rheumatology (Oxford) 41 5 2002 558 562
74. E. Selvi S.A. Tripodi M. Catenaccio Expression of macrophage migration inhibitory factor in diffuse systemic sclerosis Ann Rheum Dis 62 5 2003 460 464
75. S.P. Wu L. Leng Z. Feng Macrophage migration inhibitory factor promoter polymorphisms and the clinical expression of scleroderma Arthritis Rheum 54 11 2006 3661 3669
76. T. Kadono K. Kikuchi H. Ihn Increased production of interleukin 6 and interleukin 8 in scleroderma fibroblasts J Rheumatol 25 2 1998 296 301
77. O. Distler B. Rinkes U. Hohenleutner Expression of RANTES in biopsies of skin and upper gastrointestinal tract from patients with systemic sclerosis Rheumatol Int 19 1–2 1999 39 46
78. M. Kimura Y. Kawahito M. Hamaguchi SKL-2841, a dual antagonist of MCP-1 and MIP-1 beta, prevents bleomycin-induced skin sclerosis in mice Biomed Pharmacother 61 4 2007 222 228
79. T. Yamamoto B. Eckes T. Krieg High expression and autoinduction of monocyte chemoattractant protein-1 in scleroderma fibroblasts Eur J Immunol 31 10 2001 2936 2941
80. T. Yamamoto B. Eckes K. Hartmann Expression of monocyte chemoattractant protein-1 in the lesional skin of systemic sclerosis J Dermatol Sci 26 2 2001 133 139
81. O. Distler T. Pap O. Kowal-Bielecka Overexpression of monocyte chemoattractant protein 1 in systemic sclerosis: role of platelet-derived growth factor and effects on monocyte chemotaxis and collagen synthesis Arthritis Rheum 44 11 2001 2665 2678
82. A.M. Ferreira S. Takagawa R. Fresco Diminished induction of skin fibrosis in mice with MCP-1 deficiency J Invest Dermatol 126 8 2006 1900 1908
83. S. Karrer A.K. Bosserhoff P. Weiderer The −2518 promotor polymorphism in the MCP-1 gene is associated with systemic sclerosis J Invest Dermatol 124 1 2005 92 98
84. E.B. Lee J. Zhao J.Y. Kim Evidence of potential interaction of chemokine genes in susceptibility to systemic sclerosis Arthritis Rheum 56 7 2007 2443 2448
85. N. Tsuchiya K. Kuroki M. Fujimoto Association of a functional CD19 polymorphism with susceptibility to systemic sclerosis Arthritis Rheum 50 12 2004 4002 4007
86. Y. Hitomi N. Tsuchiya M. Hasegawa Association of CD22 gene polymorphism with susceptibility to limited cutaneous systemic sclerosis Tissue Antigens 69 3 2007 242 249
87. A.M. Abdallah E.A. Renzoni S. Anevlavis A polymorphism in the promoter region of the CD86 (B7.2) gene is associated with systemic sclerosis Int J Immunogenet 33 3 2006 155 161
88. L.L. Hudson R.M. Silver J.P. Pandey Ethnic differences in cytotoxic T lymphocyte associated antigen 4 genotype associations with systemic sclerosis J Rheumatol 31 1 2004 85 87
89. F. Takeuchi K. Kawasugi H. Nabeta Association of CTLA-4 with systemic sclerosis in Japanese patients Clin Exp Rheumatol 20 6 2002 823 828
90. S. Almasi N. Erfani Z. Mojtahedi Association of CTLA-4 gene promoter polymorphisms with systemic sclerosis in Iranian population Genes Immun 7 5 2006 401 406
91. G. Balbi F. Ferrera M. Rizzi Association of −318 C/T and +49 A/G cytotoxic T lymphocyte antigen-4 (CTLA-4) gene polymorphisms with a clinical subset of Italian patients with systemic sclerosis Clin Exp Immunol 149 1 2007 40 47
92. E. Renzoni P. Lympany P. Sestini Distribution of novel polymorphisms of the interleukin-8 and CXC receptor 1 and 2 genes in systemic sclerosis and cryptogenic fibrosing alveolitis Arthritis Rheum 43 7 2000 1633 1640
93. A. Crilly J. Hamilton C.J. Clark Analysis of the 5' flanking region of the interleukin 10 gene in patients with systemic sclerosis Rheumatology (Oxford) 42 11 2003 1295 1298
94. L. Beretta F. Cappiello M. Barili Proximal interleukin-10 gene polymorphisms in Italian patients with systemic sclerosis Tissue Antigens 69 4 2007 305 312
95. B. Granel C. Chevillard Y. Allanore Evaluation of interleukin 13 polymorphisms in systemic sclerosis Immunogenetics 58 8 2006 693 699
96. B. Granel Y. Allanore C. Chevillard IL13RA2 gene polymorphisms are associated with systemic sclerosis J Rheumatol 33 10 2006 2015 2019
97. H. Sato A.L. Lagan C. Alexopoulou The TNF-863A allele strongly associates with anticentromere antibody positivity in scleroderma Arthritis Rheum 50 2 2004 558 564
98. B. Tolusso M. Fabris R. Caporali −238 and +489 TNF-alpha along with TNF-RII gene polymorphisms associate with the diffuse phenotype in patients with systemic sclerosis Immunol Lett 96 1 2005 103 108
99. S. Assassi F.K. Tan Genetics of scleroderma: update on single nucleotide polymorphism analysis and microarrays Curr Opin Rheumatol 17 6 2005 761 767
100. A.L. Herrick J. Worthington Genetic epidemiology: systemic sclerosis Arthritis Res 4 3 2002 165 168
101. J.P. Pandey F. Takeuchi TNF-alpha and TNF-beta gene polymorphisms in systemic sclerosis Hum Immunol 60 11 1999 1128 1130
102. T. Momot S. Koch N. Hunzelmann Association of killer cell immunoglobulin-like receptors with scleroderma Arthritis Rheum 50 5 2004 1561 1565
103. M. Matucci Cerinic M.B. Kahaleh Beauty and the beast. The nitric oxide paradox in systemic sclerosis Rheumatology (Oxford) 41 8 2002 843 847
104. M.L. Biondi B. Marasini S. Leviti Genotyping method for point mutation detection in the endothelial nitric oxide synthase exon 7 using fluorescent probes. Clinical validation in systemic sclerosis patients Clin Chem Lab Med 39 3 2001 281 282
105. C. Fatini F. Gensini E. Sticchi High prevalence of polymorphisms of angiotensin-converting enzyme (I/D) and endothelial nitric oxide synthase (Glu298Asp) in patients with systemic sclerosis Am J Med 112 7 2002 540 544
106. C. Fatini L. Mannini E. Sticchi Hemorheologic profile in systemic sclerosis: role of NOS3 −786T > C and 894G > T polymorphisms in modulating both the hemorheologic parameters and the susceptibility to the disease Arthritis Rheum 54 7 2006 2263 2270
107. S. Assassi M.D. Mayes T. McNearney Polymorphisms of endothelial nitric oxide synthase and angiotensin-converting enzyme in systemic sclerosis Am J Med 118 8 2005 907 911
108. M. Tikly M. Gulumian S. Marshall Lack of association of eNOS(G894T) and p22phox NADPH oxidase submit (C242T) polymorphisms with systemic sclerosis in a cohort of French Caucasian patients Clin Chim Acta 358 1–2 2005 196 197
109. Y. Kawaguchi A. Tochimoto M. Hara NOS2 polymorphisms associated with the susceptibility to pulmonary arterial hypertension with systemic sclerosis: contribution to the transcriptional activity Arthritis Res Ther 8 4 2006 R104
110. B. Rigat C. Hubert F. Alhenc-Gelas An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels J Clin Invest 86 4 1990 1343 1346
111. O. Distler A. Del Rosso R. Giacomelli Angiogenic and angiostatic factors in systemic sclerosis: increased levels of vascular endothelial growth factor are a feature of the earliest disease stages and are associated with the absence of fingertip ulcers Arthritis Res 4 6 2002 R11
112. O. Distler J.H. Distler A. Scheid Uncontrolled expression of vascular endothelial growth factor and its receptors leads to insufficient skin angiogenesis in patients with systemic sclerosis Circ Res 95 1 2004 109 116
113. C.J. Watson N.J. Webb M.J. Bottomley Identification of polymorphisms within the vascular endothelial growth factor (VEGF) gene: correlation with variation in VEGF protein production Cytokine 12 8 2000 1232 1235
114. B. Rueda M.A. Lopez-Nevot M.J. Lopez-Diaz A functional variant of vascular endothelial growth factor is associated with severe ischemic complications in giant cell arteritis J Rheumatol 32 9 2005 1737 1741
115. Y. Allanore D. Borderie P. Airo Lack of association between three vascular endothelial growth factor gene polymorphisms and systemic sclerosis: results from a multicenter EUSTAR study of European Caucasian patients Ann Rheum Dis 66 2 2007 257 259
116. A.L. Herrick Vascular function in systemic sclerosis Curr Opin Rheumatol 12 6 2000 527 533
117. A.D. Cambrey N.K. Harrison K.E. Dawes Increased levels of endothelin-1 in bronchoalveolar lavage fluid from patients with systemic sclerosis contribute to fibroblast mitogenic activity in vitro Am J Respir Cell Mol Biol 11 4 1994 439 445
118. S. Morelli C. Ferri E. Polettini Plasma endothelin-1 levels, pulmonary hypertension, and lung fibrosis in patients with systemic sclerosis Am J Med 99 3 1995 255 260
119. C. Fonseca E. Renzoni P. Sestini Endothelin axis polymorphisms in patients with scleroderma Arthritis Rheum 54 9 2006 3034 3042
120. F. Verrecchia A. Mauviel D. Farge Transforming growth factor-beta signaling through the Smad proteins: role in systemic sclerosis Autoimmun Rev 5 8 2006 563 569
121. J. Varga Scleroderma and Smads: dysfunctional Smad family dynamics culminating in fibrosis Arthritis Rheum 46 7 2002 1703 1713
122. A. Crilly J. Hamilton C.J. Clark Analysis of transforming growth factor beta1 gene polymorphisms in patients with systemic sclerosis Ann Rheum Dis 61 8 2002 678 681
123. Y. Sugiura S. Banno Y. Matsumoto Transforming growth factor beta1 gene polymorphism in patients with systemic sclerosis J Rheumatol 30 7 2003 1520 1523
124. D.M. Bradham A. Igarashi R.L. Potter Connective tissue growth factor: a cysteine-rich mitogen secreted by human vascular endothelial cells is related to the SRC-induced immediate early gene product CEF-10 J Cell Biol 114 6 1991 1285 1294
125. T. Shimo T. Nakanishi Y. Kimura Inhibition of endogenous expression of connective tissue growth factor by its antisense oligonucleotide and antisense RNA suppresses proliferation and migration of vascular endothelial cells J Biochem (Tokyo) 124 1 1998 130 140
126. A. Leask D.J. Abraham All in the CCN family: essential matricellular signaling modulators emerge from the bunker J Cell Sci 119 Pt 23 2006 4803 4810
127. A. Igarashi K. Nashiro K. Kikuchi Connective tissue growth factor gene expression in tissue sections from localized scleroderma, keloid, and other fibrotic skin disorders J Invest Dermatol 106 4 1996 729 733
128. A. Igarashi K. Nashiro K. Kikuchi Significant correlation between connective tissue growth factor gene expression and skin sclerosis in tissue sections from patients with systemic sclerosis J Invest Dermatol 105 2 1995 280 284
129. A. Leask S. Sa A. Holmes The control of CCN2 (CTGF) gene expression in normal and scleroderma fibroblasts Mol Pathol 54 3 2001 180 183
130. C. Fonseca G.E. Lindahl M. Ponticos A polymorphism in the CTGF promoter region associated with systemic sclerosis N Engl J Med 357 12 2007 1210 1220
131. X. Zhou F.K. Tan J.D. Reveille Association of novel polymorphisms with the expression of SPARC in normal fibroblasts and with susceptibility to scleroderma Arthritis Rheum 46 11 2002 2990 2999
132. X. Zhou F.K. Tan X. Guo Attenuation of collagen production with small interfering RNA of SPARC in cultured fibroblasts from the skin of patients with scleroderma Arthritis Rheum 54 8 2006 2626 2631
133. X. Zhou F.K. Tan X. Guo Small interfering RNA inhibition of SPARC attenuates the profibrotic effect of transforming growth factor beta1 in cultured normal human fibroblasts Arthritis Rheum 52 1 2005 257 261
134. A.L. Lagan P. Pantelidis E.A. Renzoni Single-nucleotide polymorphisms in the SPARC gene are not associated with susceptibility to scleroderma Rheumatology (Oxford) 44 2 2005 197 201
135. R.M. Plenge M. Seielstad L. Padyukov TRAF1-C5 as a risk locus for rheumatoid arthritis—a genomewide study N Engl J Med 357 12 2007 1199 1209
136. E.F. Remmers R.M. Plenge A.T. Lee STAT4 and the risk of rheumatoid arthritis and systemic lupus erythematosus N Engl J Med 357 10 2007 977 986
137. N.J. Samani J. Erdmann A.S. Hall Genomewide association analysis of coronary artery disease N Engl J Med 357 5 2007 443 453
138. Genome-wide association study of 14,000 cases of seven commondiseases and 3,000 shared controls Nature 447 7145 2007 661 678
139. X. Zhou F.K. Tan N. Wang Genome-wide association study for regions of systemic sclerosis susceptibility in a Choctaw Indian population with high disease prevalence Arthritis Rheum 48 9 2003 2585 2592
140. M.L. Whitfield D.R. Finlay J.I. Murray Systemic and cell type-specific gene expression patterns in scleroderma skin Proc Natl Acad Sci U S A 100 21 2003 12319 12324
141. F.K. Tan B.A. Hildebrand M.S. Lester Classification analysis of the transcriptosome of nonlesional cultured dermal fibroblasts from systemic sclerosis patients with early disease Arthritis Rheum 52 3 2005 865 876
142. H. Gardner J.R. Shearstone R. Bandaru Gene profiling of scleroderma skin reveals robust signatures of disease that are imperfectly reflected in the transcript profiles of explanted fibroblasts Arthritis Rheum 54 6 2006 1961 1973
143. J. Pannu H. Gardner J.R. Shearstone Increased levels of transforming growth factor beta receptor type I and up-regulation of matrix gene program: a model of scleroderma Arthritis Rheum 54 9 2006 3011 3021
144. J. Pannu S. Nakerakanti E. Smith Transforming growth factor-beta receptor type I-dependent fibrogenic gene program is mediated via activation of Smad1 and ERK1/2 pathways J Biol Chem 282 14 2007 10405 10413
145. F.K. Tan X. Zhou M.D. Mayes Signatures of differentially regulated interferon gene expression and vasculotrophism in the peripheral blood cells of systemic sclerosis patients Rheumatology (Oxford) 45 6 2006 694 702
146. M.R. York T. Nagai A.J. Mangini A macrophage marker, Siglec-1, is increased on circulating monocytes in patients with systemic sclerosis and induced by type I interferons and toll-like receptor agonists Arthritis Rheum 56 3 2007 1010 1020